MNKD (MannKind) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan MannKind (MNKD)

MannKind Corporation (MNKD) is scaling its inhalation systems and pivoting toward pulmonary hypertension therapy. The issuer's forward P/E visualizes this trend, where the 84.00 mark serves as the current indicator. Royalties and a diversified pipeline support this growth, effectively mitigating risks. The ecosystem surrounding Afrezza needle-free insulin ensures customer loyalty, creating unique product value for diabetes patients.

mannkindcorp.com - Rasio kapitalisasi marang bathi mangsa ngarep MNKD (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis mannkindcorp.com (MNKD)

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental:MNKD Afrezza
Produk merek MannKind Corporation

Investors value MannKind Corporation (MNKD) for the steady growth in demand for innovative inhalation drugs. The forward P/E measures the ratio of the current share price to expected earnings, determining the extent of the premium paid for future income. By analyzing the company's expected NTM P/E on GURU.Markets, one can assess the fairness of its market value. Low values signal undervaluation, while high values reflect inflated expectations. This allows for the precise synchronization of the entry point with the potential for customer base expansion.

Pesaing MannKind Corporation

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|AMPH (Amphastar Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Corp SPRY|Theravance Biopharma - Pangali Forward P/E|Pangali forward rega marang bathi Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP